Akinci, Muge
Sánchez-Benavides, Gonzalo
Brugulat-Serrat, Anna
Peña-Gómez, Cleofé
Palpatzis, Eleni
Shekari, Mahnaz
Deulofeu, Carme
Fuentes-Julian, Sherezade
Salvadó, Gemma
González-de-Echávarri, José Maria
Suárez-Calvet, Marc
Minguillón, Carolina
Fauria, Karine
Molinuevo, José Luis
Gispert, Juan Domingo
Grau-Rivera, Oriol
Arenaza-Urquijo, Eider M.
Beteta, Annabella
Cacciaglia, Raffaele
Cañas, Alba
Cumplido, Irene
Dominguez, Ruth
Emilio, Maria
Falcon, Carles
Hernandez, Laura
Huesa, Gema
Huguet, Jordi
Marne, Paula
Menchón, Tania
Operto, Grégory
Polo, Albina
Rodríguez-Fernández, Blanca
Pradas, Sandra
Sadeghi, Iman
Soteras, Anna
Stankeviciute, Laura
Vilanova, Marc
Vilor-Tejedor, Natalia
,
Funding for this research was provided by:
Instituto de Salud Carlos III (PI19/00155)
“la Caixa” Foundation (ID 100010434)
Horizon 2020 (847648 (LCF/BQ/PR21/11840004))
Ministerio de Ciencia e Innovación (RYC-2013-13054)
Agencia Estatal de Investigación Proyectos (RTI2018-102261-B-I00)
Alzheimer’s Association (AARG 2019-AARG-644641)
Ramón y Cajal (RYC2018-026053-I)
Ministry of Science and Innovation (PID2019-111514RA-I00)
Article History
Received: 18 February 2022
Accepted: 28 August 2022
First Online: 6 September 2022
Declarations
:
: The ALFA+ study protocol and informed consent were approved by the Independent Ethics Committee “Parc de Salut Mar” (ALFA-FPM-0311) and registered at ClinicalTrials.gov (Identifier: NCT02485730). The COVID-19 protocol (CovidImpact_BBRC2020) was approved on March 16, 2020 (2020/9255). The informed consent for the COVID-19 study was obtained from all participants via an online form. All methods were carried out in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: NA.
: MSC has served as a consultant and on advisory boards for Roche Diagnostics International Ltd. and has given lectures in symposia sponsored by Roche Diagnostics, S.L.U, and Roche Farma, S.A.